Latest filing published 10 Oct 2025 for China Health Group Ltd., €9,286. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Xing Yong discloses dealings in China Health Group Ltd. to HKEX. Over a trading history stretching from 24 October 2017 to 6 October 2025, the count stands at 5 filings.
The open-market record is one-sided, with 5 purchases worth €32k and not one sale. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 1 purchase and no sales on the market.
Half of the purchases are above €9,286 and half below. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -7.4%. This is a record of the past, not a forecast.
On 10 October 2025 came the latest disclosure, an open-market purchase for €9,286 in China Health Group Ltd. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations